Behavioral Interventions for Cardiovascular Disease
(BETTER P2 Trial)
Trial Summary
Do I need to stop my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the idea that Behavioral Interventions for Cardiovascular Disease is an effective treatment?
The available research shows that behavioral interventions, like message framing and financial incentives, can positively influence health behaviors. For example, message framing has been effective in improving self-management activities in patients with diabetes, which suggests it could also help those with cardiovascular disease. Additionally, financial incentives have been used successfully in trials to lower cholesterol levels, indicating potential benefits for heart health. These findings suggest that behavioral interventions can be a useful treatment for cardiovascular disease by encouraging healthier behaviors.12345
What safety data exists for the behavioral interventions for cardiovascular disease?
The provided research does not directly address safety data for the behavioral interventions for cardiovascular disease or the specific treatments mentioned (Framing Method variations, Lynparza, AZD-2281, MK-7339, KU0059436). The studies focus on risk literacy, framing effects on cardiovascular risk, participant knowledge, and communication of trial results, but do not provide safety data for the interventions in question.678910
Is the treatment in the trial 'Behavioral Interventions for Cardiovascular Disease' a promising treatment?
Yes, behavioral interventions are promising for treating cardiovascular disease. They help people change habits like exercise and diet, which can lower the risk of heart problems. These interventions use techniques like setting goals and self-monitoring, making it easier for people to stick to healthier lifestyles.1112131415
What is the purpose of this trial?
Problem. Randomized clinical trials (RCTs) are the best way to determine if interventions are safe and effective. Usually only a small number of eligible patients enroll. This is because trials require people to consent to be enrolled and randomized. Black and Hispanic people are more likely to develop heart disease. They are also more likely to have risk factors for heart disease that are not controlled. Yet they are very under-represented in heart disease trials. This raises concerns about if trial results can be applied to the general population. Trial sponsors are required to enroll patients that reflect the racial and ethnic diversity of real-world people. Black and Hispanic people continue to enroll in trials at a lower rate. The goal of this study is to conduct a series of small randomized trials to test recruitment strategies to increase how many Black and Hispanic people enroll in heart disease clinical trials without diminishing trust. The investigators will test different recruitment strategies for participant enrollment in a few different areas. They will study the method of outreach, the way messages are framed, defaults, and enrollment incentives. They will run smaller recruitment strategy trials within larger parent trials (e.g. Penn Medicine Biobank cohort study). They will run a small recruitment strategy trial to test each approach and then include what they learned in the next small trial.
Eligibility Criteria
This trial is for Black and Hispanic individuals with active medical records at the participating site. It aims to improve diversity in cardiovascular disease studies by testing different recruitment strategies.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Recruitment Strategy Testing
Testing different recruitment strategies to increase enrollment of Black and Hispanic individuals in cardiovascular cohort studies
Follow-up
Participants are monitored for enrollment outcomes and trust in medical researchers
Treatment Details
Interventions
- Framing Method (Appeal to Altruism)
- Framing Method (Opt-Out)
- Framing Method (Social Proof or Perceived Scarcity)
- Incentive Structure
- Method of Contact
- Source of Contact
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
American Heart Association
Collaborator
Emory University
Collaborator